Advertisement
Canada markets close in 35 minutes
  • S&P/TSX

    21,494.84
    -116.46 (-0.54%)
     
  • S&P 500

    5,487.03
    +13.80 (+0.25%)
     
  • DOW

    38,834.86
    +56.76 (+0.15%)
     
  • CAD/USD

    0.7293
    +0.0001 (+0.01%)
     
  • CRUDE OIL

    81.47
    -0.10 (-0.12%)
     
  • Bitcoin CAD

    88,897.45
    +508.98 (+0.58%)
     
  • CMC Crypto 200

    1,382.80
    +45.04 (+3.37%)
     
  • GOLD FUTURES

    2,342.70
    -4.20 (-0.18%)
     
  • RUSSELL 2000

    2,025.23
    +3.22 (+0.16%)
     
  • 10-Yr Bond

    4.2170
    0.0000 (0.00%)
     
  • NASDAQ

    17,862.23
    +5.21 (+0.03%)
     
  • VOLATILITY

    12.48
    +0.18 (+1.46%)
     
  • FTSE

    8,205.11
    +13.82 (+0.17%)
     
  • NIKKEI 225

    38,570.76
    +88.65 (+0.23%)
     
  • CAD/EUR

    0.6785
    0.0000 (0.00%)
     

OPKO Health to Participate in the Jefferies Global Healthcare Conference

OPKO Health, Inc.
OPKO Health, Inc.

MIAMI, May 31, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Global Healthcare Conference, being held June 4-6, 2024 at the Marriott Marquis in New York City. Management will be holding one-on-one meetings with investors and will be participating in a fireside discussion on Thursday, June 6th at 10:30 a.m. Eastern time.

The fireside chat will be webcast live and available for replay in the Investors section of OPKO Health’s website and accessible by clicking here.

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.

Contacts:

LHA Investor Relations
Yvonne Briggs, 310-691-7100
ybriggs@lhai.com
or
Bruce Voss, 310-691-7100
bvoss@lhai.com